Headline Details

How the Actavis deal upended Allergan No. 2's CEO ambitions

Published on: Tue, 03 Feb 2015 18:40:57 UTC
News Agency: Reuters
NEW YORK (Reuters) - For two decades, Allergan Inc president Doug Ingram labored to transform the Botox-maker from a sleepy eye care upstart to a global aesthetics giant. He was just a few months away from getting the top job when a merger deal with Actavis Plc in November thwarted his ambitions.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
Italian man tries to dodge Covid jab using fake arm BBC
Austria ruling party picks Nehammer for chancellor BBC
Omicron coronavirus variant: Your questions answered BBC
Ghislaine Maxwell: Employee told 'not to look Jeffrey Epstein in the eye' BBC
US government shutdown averted hours before deadline BBC